IMPROVE AKI Cluster-Randomized Trial

NACompletedINTERVENTIONAL
Enrollment

10,252

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

January 31, 2023

Conditions
Acute Kidney Injury
Interventions
BEHAVIORAL

AKI Prevention Toolkit

AKI Prevention Toolkit. Intervention: All sites will receive the AKI Prevention Toolkit including 3 core interventions: 1. Standardized order sets; 2. IV and oral fluids; and 3. Reduced contrast volume. The interventions adhere to the KDIGO guidelines and add interventions developed and tested in our pilot intervention to implement AKI preventive strategies.

BEHAVIORAL

Technical Assistance (TA)

Technical Assistance (TA). Intervention: TA will be offered to the 8 teams randomized to the TA condition and will receive the AKI Prevention Toolkit plus monthly technical calls independently. TA arms will include TA with and without automated surveillance reporting (ASR).

BEHAVIORAL

Virtual Learning Collaborative (VLC)

Virtual Learning Collaborative (VLC). Intervention: The VLC will be offered to 8 teams and will receive the AKI Prevention Toolkit plus monthly virtual training calls with the other VLC sites. Each participating site will be supported to establish a multidisciplinary team charged with continuously improving AKI, which will include interventional cardiologists, cardiac catheterization lab manager and technicians, nursing representatives from the intensive care unit and/or holding areas, cardiology administration, nephrology, and representation from the quality improvement department (VA Clinical Application Coordinator \[CAC\] and Systems Redesign). VLC arms will include VLC with and without automated surveillance reporting (ASR).

BEHAVIORAL

Automated Surveillance Reporting (ASR)

Automated Surveillance Reporting (ASR). Intervention: The ASR will be offered to 8 teams. In addition to either TA or VLC, ASR teams will receive automated monthly reports in the form of an dashboard focused on AKI outcome and preventative measures overtime. The ASR report will be customized to each team and each individual operator and linked to their national VA-CART registry.

Trial Locations (2)

37212

Tennesee Valley VA, Nashville

05001

White River Junction VA, White River Junction

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

collaborator

University of Vermont

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT03556293 - IMPROVE AKI Cluster-Randomized Trial | Biotech Hunter | Biotech Hunter